8329 Share Price

Open 0.50 Change Price %
High 0.51 1 Day 0.00 0.00
Low 0.49 1 Week -0.03 -5.56
Close 0.51 1 Month -0.04 -7.27
Volume 3270000 1 Year -0.19 -27.14
52 Week High 0.71
52 Week Low 0.49
8329 Important Levels
Resistance 2 0.53
Resistance 1 0.52
Pivot 0.50
Support 1 0.50
Support 2 0.49
HKG HongKong Most Active Stocks
0136 0.57 -17.39%
0261 0.01 0.00%
0566 3.91 0.00%
8173 0.01 -66.67%
0939 5.79 -0.17%
2324 0.06 -14.29%
3988 3.52 -0.56%
1398 4.77 0.42%
0981 1.00 0.00%
0061 0.02 0.00%
More..
HKG HongKong Top Gainers Stocks
0412 0.59 31.11%
8037 0.32 28.00%
0915 3.06 22.40%
0395 0.14 16.67%
8220 0.17 13.33%
8200 0.10 11.11%
8057 2.15 10.26%
0281 0.54 10.20%
3828 1.31 10.08%
8116 0.22 10.00%
More..
HKG HongKong Top Losers Stocks
8173 0.01 -66.67%
8231 0.25 -28.57%
4333 60.00 -25.00%
0136 0.57 -17.39%
8002 4.00 -15.97%
2324 0.06 -14.29%
1555 0.79 -14.13%
8081 0.09 -10.00%
8286 0.54 -10.00%
8201 0.09 -10.00%
More..

Shenzhen Neptunus (HKG: 8329)

8329 Technical Analysis 5
As on 5th Dec 2016 8329 Share Price closed @ 0.51 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.59 & Strong Sell for SHORT-TERM with Stoploss of 0.55 we also expect STOCK to react on Following IMPORTANT LEVELS.
8329 Target for December
1st Target up-side 0.57
2nd Target up-side 0.59
3rd Target up-side 0.62
1st Target down-side 0.49
2nd Target down-side 0.47
3rd Target down-side 0.44
8329 Other Details
Segment EQ
Market Capital 0.00
Sector Basic Materials
Industry Chemicals - Major Diversified
Offical website http://www.interlong.com
8329 Address
8329
United Centre
18th Floor
Admiralty,
Hong Kong
Interactive Technical Analysis Chart Shenzhen Neptunus ( 8329 HKG HongKong )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Shenzhen Neptunus
8329 Business Profile
Shenzhen Neptunus Interlong Bio-Technique Company limited is engaged in the research and development, production, sale, and distribution of gene engineering drugs and preventive biological products in the People’s Republic of China. It offers herbal medicines, generic drugs, and transfusion and anti-tumor drugs. The company’s products include INTERKING Recombinant Human Interleukin-2 (125 Ser) for injection to treat renal cell carcinoma, melanoma, breast carcinoma, bladder cancer, liver carcinoma, rectal cancer, lymphoma, lung cancer, and carcinomatous thoracico-ascites; and INTERLONG Recombinant Human Interferon a-2b for injection to treat viral diseases, including acute and chronic hepatitis, herpes zoster, and condylomata acuminate, as well as tumors, including hairy cell leukemia, chronic myelocytic leukemia, multiple myeloma, non-Hodgkin’s lymphomas, malignant melanoma, kidney cell cancer, laryngeal papilloma, kaposis sarcoma, oophoroma, basal cell carcinoma, and bladder cancer. It is also engaged in the research and development of various cytokines products, vaccines, and biopharmaceutical products. In addition, the company is involved in the production of chemical medicine; and wholesale and retail of packaging materials and pre-packaged food. Shenzhen Neptunus Interlong Bio-Technique Company limited sells its products in approximately 20 provinces in the People’s Republic of China, as well as serves approximately 500 medical organizations. The company is based in Admiralty, Hong Kong. Shenzhen Neptunus Interlong Bio-technique Company Limited is a subsidiary of Shenzhen Neptunus Bio-engineering Co., Ltd.